Curtis Engelhart

8PUBLICATIONS
67CO-AUTHORS
Medical bacteriologyMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyComputational physiologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13.

Inna V Krieger, Paridhi Sukheja, Baiyuan Yang

|May 02, 2025
Tailored phenyl ureas eradicate drug-resistant Mycobacterium tuberculosis by targeting mycolic acid cell wall assembly.

Dietrich Mostert, Josef Braun, Matthew D Zimmerman

|Oct 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs.

Simon R Green, Susan H Davis, Sebastian Damerow

|May 31, 2022
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis.

Shuqi Li, Nicholas C Poulton, Jesseon S Chang

|Nov 02, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development.

Tiago Beites, Kathryn O'Brien, Divya Tiwari

|Feb 02, 2019
Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition.

Elaine Ballinger, John Mosior, Travis Hartman

Pageof 2